Pomalyst (pomalidomide) — Medica
Systemic light chain amyloidosis
Initial criteria
- Patient is ≥ 18 years of age
- Medication is used in combination with dexamethasone
- Patient has tried at least one other regimen
Approval duration
1 year
Systemic light chain amyloidosis
1 year